Heterogeneity in response to N‐acetylcysteine in vascular mild cognitive impairment
These findings show significant variability in response to NAC among vMCI patients, with certain subgroups showing more pronounced benefits. This highlights the need for personalized therapeutic strategies targeting OS in vMCI.
Authors
- Yejin Kang (ORCID: https://orcid.org/0000-0002-3436-1846)
- Alex Kiss
- Damien Gallagher (ORCID: https://orcid.org/0000-0001-8952-3200)
- Joel Ramirez (ORCID: https://orcid.org/0000-0002-5582-1776)
- P. OH
- Walter Swardfager
- Nathan Herrmann
- Krista L Lanctôt
- Sandra E. Black
Institutions
- Sunnybrook Health Science Centre (CA)
- University Health Network (CA)
- University of Toronto (CA)
- Toronto Rehabilitation Institute (CA)
- Health Sciences Centre (CA)
- Sunnybrook Hospital (CA)
- Sunnybrook Research Institute
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_107036
- Primary Topic
- Neurological Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00